Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...

By focusing on chromatin-modifying enzymes, viral proteins, and noncoding RNAs, the researchers hope to uncover new pathways for a functional cure for chronic hepatitis B. The review highlights the ...

An antisense drug developed by GlaxoSmithKline has been shown to suppress the hepatitis B virus (HBV) in a phase 2 trial, raising hopes of a “functional cure” for the widespread disease.

This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

Screening tests such as mammograms for breast cancer and sigmoidoscopy or fecal occult blood testing for colorectal cancer have proven effective in catching cancer early, increasing the chances of a ...

Hop On A Cure Logo Hop On A Cure logo in blue 'To witness the growth of Hop On A Cure and the continued giving from sponsors, donors, and friends, has been overwhelming,' said Hopkins. 'Every dollar ...

NEW YORK, March 6, 2025 /PRNewswire/ -- Cure, a premier healthcare innovation ecosystem headquartered in New York City, is set to host the Power of X Summit: Solutions for an Untapped Market, March 24 ...

Objective Vaccination against hepatitis B virus (HBV) confers protection from subsequent infection through immunological memory that is traditionally considered the domain of the adaptive immune ...